Showing 721-730 of 836 results for "".
- 5 Things We Can’t Wait to See at the 2024 Octane Aesthetics Tech Forumhttps://modernaesthetics.com/news/5-things-we-cant-wait-to-see-at-octane-aesthetics-tech-forum-2024/2473543/In a world where technology, artistry, and business are increasingly intersecting, the Octane Aesthetics Tech Forum 2024 running January 25 – 26 in Newport Beach, CA is rapidly becoming a “must” for anyone working in the field. Under the theme 'Forging the Future of Aestheti
- The Art of Saying Nohttps://modernaesthetics.com/news/the-art-of-saying-no/2473533/Most cosmetic dermatologists and plastic surgeons have encountered a patient (or patients) with unreasonable expectations and know intuitively that these patients won’t be satisfied with the outcome of a requested procedure. Still, it can be hard to say no, especially when the doc
- Amogh Kothare Is Advalight’s New Chief Scientific Officerhttps://modernaesthetics.com/news/amogh-kothare-is-advalights-new-chief-scientific-officer/2473532/Amogh Kothare is the new Chief Scientific Officer of Advalight. In this role, Mr. Kothare will be responsible for clinical research, partnerships, product management, and clinical affairs and training to further leverage the brand. A "Under Amogh's sci
- Allergan Aesthetics and The Black Beauty Club Partner to Foster Diversity in Aestheticshttps://modernaesthetics.com/news/allergan-aesthetics-x-the-black-beauty-club-partner-to-advance-diversity-in-aesthetics/2473531/Allergan Aesthetics joined forces with the Black Beauty Club for a consumer initiative to spark open dialogue and empower Black individuals to embrace their unique beauty and make informed decisions about their aesthetic care. The event, which took place in Atlanta on Novembe
- Exosome Update: ELEVAI Labs Announces Pricing of $6,000,000 IPOhttps://modernaesthetics.com/news/exosome-update-elevai-labs-announces-pricing-of-6000000-ipo/2473530/Elevai Labs, Inc. announced the pricing of its initial public offering. The Offering consists of 1,500,000 shares of common stock at a public offering price of $4.00 per share, for total gross proceeds of $6,000,000 before deducting underwriting discounts and o
- AestheticsWire Exclusive: Embracing Diversity in Aestheticshttps://modernaesthetics.com/news/embracing-diversity-in-aesthetics/2473528/There’s no such thing as a one-size-fits-all approach to rejuvenation as people across genders, ethnicities, and age groups often have different concerns and aesthetic goals. This is the main takeaway from a new study that sought to better understand facial and body aesthetic conc
- Hair Relaxers Linked to Uterine Cancer in Black Womenhttps://modernaesthetics.com/news/hair-relaxers-linked-to-uterine-cancer-in-black-women/2473506/Long-term use of chemical hair relaxers by postmenopausal Black women may increase risk of uterine cancer, according to a new study by researchers at Boston University’s Black Women’s Health Study (BWHS). These products contain potentially harmful ingredients, including chem
- Meet the Beauty Health Company’s New CFO: Michael Monahanhttps://modernaesthetics.com/news/meet-the-beauty-health-companys-new-ceo-michael-monahan/2473471/Michael Monahan is The Beauty Health Company’s new Chief Financial Officer, effective August 10, 2023. He succeeds Liyuan Woo, who is leaving BeautyHealth but will remain as an advisor until September 1, 2023 to assist with the transition. "Michael
- New Skin-Responsive FUE Technique Improves Hair Restoration Results Among Individuals of African Descent,https://modernaesthetics.com/news/new-skin-responsive-fue-technique-improves-hair-restoration-results-among-individuals-of-african-descent/2473468/A new follicular unit excision (FUE) device may improve hair restoration results among individuals of African descent, according to a study in Dermatologic
- News You Can Use: RVL Rolls Out New Prescription E-commerce Platform, ELEVATEhttps://modernaesthetics.com/news/news-you-can-use-rvl-rolls-out-new-prescription-e-commerce-platform-elevate/2473442/RVL Pharmaceuticals is launching a prescription e-commerce platform. ELEVATE is a secure subscription platform that allows both providers and patients to purchase RVL products. The platform comprises RVL-initiated auto refills and unlocks additional&nb